Stockreport

Xencor, Inc. (XNCR) Discusses Initial Phase I Dose Escalation Results for XmAb819 in Advanced Clear Cell Renal Cell Carcinoma Transcript [Seeking Alpha]

Xencor, Inc.  (XNCR) 
Last xencor, inc. earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.xencor.com/investor-relations
PDF Company Participants Charles Liles - Associate Director and Head of Corporate Communications & Investor Relations Bassil Dahiyat - Co-Founder, CEO, President & Dire [Read more]